Blocking phosphoinositide 3-kinase activity in colorectal cancer cells reduces proliferation but does not increase apoptosis alone or in combination with cytotoxic drugs.
about
Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational status.The dual PI3K/mTOR inhibitor NVP-BEZ235 induces tumor regression in a genetically engineered mouse model of PIK3CA wild-type colorectal cancer.ERBB3 knockdown induces cell cycle arrest and activation of Bak and Bax-dependent apoptosis in colon cancer cells.Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT PathwayXIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis.The micosporine-like amino acids-rich aqueous methanol extract of laver (Porphyra yezoensis) inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytes[18F]-FLT positron emission tomography can be used to image the response of sensitive tumors to PI3-kinase inhibition with the novel agent GDC-0941.Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer.BMX acts downstream of PI3K to promote colorectal cancer cell survival and pathway inhibition sensitizes to the BH3 mimetic ABT-737.Src family kinase inhibitor Saracatinib (AZD0530) impairs oxaliplatin uptake in colorectal cancer cells and blocks organic cation transporters.A caspase-3 'death-switch' in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell death biomarkers
P2860
Q33999493-4FA1A7A6-F288-4A03-BDDA-4029E0529469Q34038031-7B798A36-D20C-4631-A7E6-67E8F21C74ABQ34104165-2F2DD7FF-7CE0-4234-A9E6-CA03C6F58705Q36255950-A94EC691-E008-48B0-8549-D1C644C6328CQ36292020-AE5A0C06-EDE2-4BD3-A0D7-8842705F26A8Q36340068-15F2315D-66CB-4B2B-88A8-E18E4DBAA736Q36894808-60449604-1123-4C07-B1E4-A120ECB85729Q37593559-CC39BEFC-2B09-45F6-BA8A-80DEADB5082EQ38643329-003D7BD3-E9FB-47AD-9EC3-A0364A4131A8Q41827401-42A4D750-6144-4D41-ACFF-E7740848EE4FQ42142229-B49CB55B-05F8-497C-AE26-A49A18F0C447
P2860
Blocking phosphoinositide 3-kinase activity in colorectal cancer cells reduces proliferation but does not increase apoptosis alone or in combination with cytotoxic drugs.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Blocking phosphoinositide 3-ki ...... bination with cytotoxic drugs.
@ast
Blocking phosphoinositide 3-ki ...... bination with cytotoxic drugs.
@en
type
label
Blocking phosphoinositide 3-ki ...... bination with cytotoxic drugs.
@ast
Blocking phosphoinositide 3-ki ...... bination with cytotoxic drugs.
@en
prefLabel
Blocking phosphoinositide 3-ki ...... bination with cytotoxic drugs.
@ast
Blocking phosphoinositide 3-ki ...... bination with cytotoxic drugs.
@en
P2093
P2860
P1476
Blocking phosphoinositide 3-ki ...... bination with cytotoxic drugs.
@en
P2093
Arkadiusz Welman
Cassandra Hodgkinson
Christopher J Morrow
Cristina Martin-Fernandez
Juliana Bales
Melanie J Welham
P2860
P304
P356
10.1158/1541-7786.MCR-08-0445
P577
2009-06-09T00:00:00Z